Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
第一作者:
Mahsa,Moeinian
第一单位:
Mahsa Moeinian, Seyedeh Farnaz Ghasemi-Niri, Shilan Mozaffari, Maryam Baeeri, Mona Navaea-Nigjeh, Mohammad Abdollahi, Department of Toxicology and Pharmacology, Toxicology and Poisoning Research Center, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran.
作者:
医学主题词
动物(Animals);消炎药(Anti-Inflammatory Agents);抗氧化剂(Antioxidants);酪酸(Butyric Acid);肉碱(Carnitine);结肠炎(Colitis);结肠(Colon);综合疗法(Combined Modality Therapy);疾病模型, 动物(Disease Models, Animal);胃肠病用药(Gastrointestinal Agents);炎症介导素类(Inflammation Mediators);男(雄)性(Male);氧化性应激(Oxidative Stress);有益菌种(Probiotics);大鼠, Wistar(Rats, Wistar);时间因素(Time Factors);三硝基苯磺酸(Trinitrobenzenesulfonic Acid)
DOI
10.3748/wjg.v20.i31.10876
PMID
25152589
发布时间
2022-12-07
- 浏览54
World journal of gastroenterology
2014年20卷31期
10876-85页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



